Publication | Closed Access

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

HepatologyMedicinePathologyLiver CancerCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma